* OptiNose Inc OPTN.OQ OPTN.O is expected to show a rise in
quarterly revenue when it reports results on November 3
(estimated).
* The Yardley, Pennsylvania-based company is expected to report
a 52.1% increase in revenue to $23.484 million from $15.44
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for OptiNose Inc is for a
loss of 36 cents per share. For the same quarter last year, the
company reported a loss of 43 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for OptiNose Inc is
$12, about 77.9% above its last closing price of $2.65.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 302021 -0.40 -0.41 -0.44 Missed -6.3
Mar. 312021 -0.53 -0.53 -0.49 Beat 7.5
Dec. 312020 -0.46 -0.46 -0.46 Met 0.4
Sep. 302020 -0.51 -0.52 -0.43 Beat 17.8
Jun. -0.55 -0.56 -0.56 Met 0
302020
Mar. 312020 -0.66 -0.65 -0.63 Beat 3.8
Dec. 312019 -0.61 -0.62 -0.58 Beat 6.5
Sep. 302019 -0.69 -0.69 -0.69 Met 0
This summary was machine generated November 1 at 18:27 GMT. All
figures in US dollars unless otherwise stated